NPPA directs strict monitoring of TMR for 137 cancer drugs

GreyOak summary

The National Pharmaceutical Pricing Authority (NPPA) has issued strict directives to state drug controllers regarding the implementation of Trade Margin Rationalization (TMR) for 137 non-scheduled cancer drugs. These modified prices, effective from September 9, 2026, are available on the NPPA website and the 'Pharma Sahi Daam' portal. State controllers are instructed to submit reports on actions taken by November 16, 2026.